Specifically, the acetylcholine produced by the vagus nerve can bind to the α-7 nicotinic acetylcholine receptor expressed on tissue macrophages and inhibit the release of inflammatory cytokines through signal transduction of receptors, such as interleukin-1 (IL-1), interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α), blocking the interaction between tumour cells and the surrounding inflammatory microenvironment31,32. The gene discussed is IL1B; the disease is neoplasm.